2,388 results match your criteria: "Toulouse University hospital[Affiliation]"

Accurate segmentation of thalamic nuclei, crucial for understanding their role in healthy cognition and in pathologies, is challenging to achieve on standard T1-weighted (T1w) magnetic resonance imaging (MRI) due to poor image contrast. White-matter-nulled (WMn) MRI sequences improve intrathalamic contrast but are not part of clinical protocols or extant databases. In this study, we introduce histogram-based polynomial synthesis (HIPS), a fast preprocessing transform step that synthesizes WMn-like image contrast from standard T1w MRI using a polynomial approximation for intensity transformation.

View Article and Find Full Text PDF

Recently, novel non-pharmacological interventions, such as photobiomodulation (PBM) therapy, have shown promise for the treatment of Alzheimer's disease (AD). This article outlines the translation from the preclinical to clinical stages of an innovative brain-gut PBM therapy in a mouse model of AD, a pilot clinical trial involving mild-to-moderate AD patients, and a continuing pivotal clinical trial with a similar patient population. In a mouse model of AD (Aβ25-35), daily application of brain-gut PBM therapy to both the head and the abdomen produced a neuroprotective effect against the neurotoxic effects of an Aβ25-35 peptide injection by normalizing all the modified behavioral and biochemical parameters.

View Article and Find Full Text PDF

Background: One randomized phase III trial comparing chemotherapy (CT) with immune checkpoint inhibitors (ICI) has demonstrated significant efficacy of ICI in deficient DNA mismatch repair system/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer. However, few studies have compared ICI with CT in other advanced dMMR/MSI-H digestive tumors.

Methods: In this multicenter study, we included patients with advanced dMMR/MSI-H non-colorectal digestive tumors treated with chemotherapy and/or ICIs.

View Article and Find Full Text PDF

Purpose: Corneal crosslinking (CXL) is the standard treatment of progressive keratoconus (KC). We evaluated the safety and 10-year outcomes of conventional "epithelial-off" CXL for progressive KC for the first time in a cohort in France.

Methods: We conducted a retrospective review of patients undergoing conventional CXL (Dresden protocol) in our tertiary ophthalmology department from 2006 to 2011 with 10-year follow-up.

View Article and Find Full Text PDF

Increased trend in dementia incidence within a Taiwanese National Cohort: What have we learned? What can we do?

Arch Gerontol Geriatr

June 2024

Institut Hospitalo Universitaire HealthAge, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse, France; Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse, France.

View Article and Find Full Text PDF

Correlation and causation dermatology.

J Eur Acad Dermatol Venereol

April 2024

AGING Team, CERPOP, UMR1295, Toulouse University III, Toulouse, France.

View Article and Find Full Text PDF

Zinc unbound concentration as an anchor to drive individualize repletion.

Clin Nutr

April 2024

Department of Biochemistry, Toulouse University Hospital, Toulouse, France; Institut RESTORE, UMR 1301 INSERM, 5070 CNRS, Université Paul Sabatier, Toulouse, France.

Background And Aims: Zinc (Zn) quantification is of particular interest in many clinical condition (e.g. inflammatory disease, critical care).

View Article and Find Full Text PDF

Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.

Clin Immunol

May 2024

Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, UK; Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Electronic address:

Article Synopsis
  • Type I interferon (T1IFN) is linked to disease activity in systemic lupus erythematosus (SLE), and juvenile-onset SLE (jSLE) has higher disease severity likely due to genetic factors.
  • A study genotyped 319 jSLE patients to examine gene polymorphisms associated with age of onset and disease characteristics, identifying 10 significant quantitative trait loci (QTL).
  • The findings indicate that T1IFN-related genetic variations could help tailor treatment strategies for jSLE patients, leading to more personalized care.
View Article and Find Full Text PDF

Introduction: In Moyamoya angiopathy (MMA), mechanisms underlying cognitive impairment remain debated. We aimed to assess the association of cognitive impairment with the degree and the topography of cerebral hypoperfusion in MMA.

Methods: A retrospective analysis of neuropsychological and perfusion MRI data from adults with MMA was performed.

View Article and Find Full Text PDF

Background: The prevalence and risk factors of posttraumatic stress disorder after cesarean delivery, outside high-risk contexts, remain unclear.

Objective: This study aimed to assess posttraumatic stress disorder prevalence and risk factors at 2 months postpartum among a general population of women with cesarean delivery.

Study Design: This was a prospective ancillary cohort study of the Tranexamic Acid for Preventing Postpartum Hemorrhage after Cesarean Delivery (TRAAP2) trial, conducted in 27 French hospitals from 2018 to 2020, enrolling women expected to undergo cesarean delivery before or during labor at ≥34 weeks of gestation.

View Article and Find Full Text PDF

Background: Addition of anti-GD2 antibodies to temozolomide-based chemotherapy has demonstrated increased antitumor activity and progression-free survival in patients with relapsed/progressive high-risk neuroblastoma. However, chemo-immunotherapy is not yet approved for this indication. This study presents the chemo-immunotherapy experience in patients with relapsed/progressive high-risk neuroblastoma treated within the off-label use program of the Neuroblastoma Committee of the French Society of Pediatric Oncology (SFCE).

View Article and Find Full Text PDF
Article Synopsis
  • * Real-world data shows that many patients continue to experience controlled disease activity for several years after the initial treatment, even though the official guidance does not extend beyond this period.
  • * A group of expert neurologists provides recommendations on how to start and switch to CladT, manage treatment during the first two years, and handle ongoing care in later years to optimize treatment benefits and limit MS progression.
View Article and Find Full Text PDF
Article Synopsis
  • About 20% of neonates with congenital cytomegalovirus (cCMV) experience long-term health issues, making early prediction of outcomes crucial for treatment and counseling.
  • The study followed 227 neonates diagnosed with cCMV to identify predictive markers; key findings showed maternal primary infection during the first trimester greatly increased the risk of negative outcomes.
  • A model using normal hearing, platelet count, and cranial ultrasound at birth showed high specificity and can help clinicians tailor care for cCMV-affected neonates.
View Article and Find Full Text PDF

P2Y13 receptor deficiency favors adipose tissue lipolysis and worsens insulin resistance and fatty liver disease.

JCI Insight

March 2024

LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.

Excessive lipolysis in white adipose tissue (WAT) leads to insulin resistance (IR) and ectopic fat accumulation in insulin-sensitive tissues. However, the impact of Gi-coupled receptors in restraining adipocyte lipolysis through inhibition of cAMP production remained poorly elucidated. Given that the Gi-coupled P2Y13 receptor (P2Y13-R) is a purinergic receptor expressed in WAT, we investigated its role in adipocyte lipolysis and its effect on IR and metabolic dysfunction-associated steatotic liver disease (MASLD).

View Article and Find Full Text PDF
Article Synopsis
  • Guidelines worldwide endorse exercise as a key treatment for patients with lower extremity peripheral artery disease (PAD).
  • Structured exercise programs yield the best outcomes, and this paper aims to help establish these programs for patients with chronic PAD.
  • It discusses specific exercise protocols, assesses patient outcomes based on evidence, and addresses disparities in access to supervised programs across Europe, pointing out areas needing further research.
View Article and Find Full Text PDF

Purpose: In order to explore clinical pharmacology and therapeutics (CPT) teaching and practices across continental Europe, the European Association of Clinical Pharmacology and Therapeutics (EACPT) made a survey in 2022 amongst its 27 affiliated societies.

Methods: The survey was made available online to EACPT representatives, and 47 filled-in questionnaires were received from 25 countries (one to five per country), representing all geographic areas of Europe.

Results: Clinical pharmacologists (CPs) spend 25%, 30%, 15%, and 25% of their time in teaching, hospital activities, committees, and research, respectively, with large variations across and within countries.

View Article and Find Full Text PDF
Article Synopsis
  • - The Banff Working Group on Liver Allograft Pathology convened in September 2022 with a diverse group of experts to discuss long-term health monitoring of liver transplants, focusing on noninvasive methods and optimizing immunosuppression.
  • - The group considered revising the rejection classification scheme to better identify and communicate late T cell-mediated rejection patterns and related changes, like nodular regenerative hyperplasia.
  • - They emphasized the need for personalized immunosuppression strategies based on individual patient needs and proposed incorporating interface hepatitis and fibrosis staging into the rejection classification, which will undergo further testing and discussion before the next conference.
View Article and Find Full Text PDF

Exercise therapy for chronic symptomatic peripheral artery disease.

Eur Heart J

April 2024

Angiology Unit, Ospedale Castelfranco Veneto, Castelfranco Veneto, Italy.

Article Synopsis
  • Exercise is highly recommended globally as an essential part of managing lower extremity peripheral artery disease (PAD) to improve patient outcomes.
  • This paper aims to help clinicians create effective structured exercise programs tailored for patients with symptomatic chronic PAD, detailing various training protocols and assessment methods.
  • It also addresses the unequal access to supervised exercise programs across Europe and points out the need for more research in this area.
View Article and Find Full Text PDF

Exercise therapy for chronic symptomatic peripheral artery disease.

Vasa

April 2024

Angiology Unit, Ospedale Castelfranco Veneto, Castelfranco Veneto, Italy.

Article Synopsis
  • Exercise is essential for managing lower extremity peripheral artery disease (PAD), and guidelines worldwide strongly support its use.
  • A structured exercise program is crucial for achieving the best results in patients with symptomatic chronic PAD, with various training protocols outlined.
  • The document also addresses disparities in access to supervised exercise programs in Europe and identifies areas where more research is needed.
View Article and Find Full Text PDF

Real-world artificial intelligence-based interpretation of fundus imaging as part of an eyewear prescription renewal protocol.

J Fr Ophtalmol

June 2024

Ophthalmology Department, Clinique Honoré-Cave, Montauban, France. Electronic address:

Objective: A real-world evaluation of the diagnostic accuracy of the Opthai® software for artificial intelligence-based detection of fundus image abnormalities in the context of the French eyewear prescription renewal protocol (RNO).

Methods: A single-center, retrospective review of the sensitivity and specificity of the software in detecting fundus abnormalities among consecutive patients seen in our ophthalmology center in the context of the RNO protocol from July 28 through October 22, 2021. We compared abnormalities detected by the software operated by ophthalmic technicians (index test) to diagnoses confirmed by the ophthalmologist following additional examinations and/or consultation (reference test).

View Article and Find Full Text PDF

Drugs for Alzheimer's disease: Where are we coming from? Where are we going?

Sci Bull (Beijing)

May 2024

Institut Hospitalo Universitaire HealthAge, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse 31000, France; Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse 31000, France.

View Article and Find Full Text PDF

Objective: In France, kidney transplantations (KT) are mainly performed by urologist. Young urologists and residents are involved in this activity mostly performed in emergency. How do they feel about KT training? Is KT an attractive part of the urologist activity?

Methods: This survey has been designed in the form of a questionnaire by the French Committee of Kidney Transplantation (CTAFU) and the French Association of Urologists in training (AFUF).

View Article and Find Full Text PDF

Background: Health-related quality of life (Hr-QoL) scales provide crucial information on neurodegenerative disease progression, help improve patient care and constitute a meaningful endpoint for therapeutic research. However, Hr-QoL progression is usually poorly documented, as for multiple system atrophy (MSA), a rare and rapidly progressing alpha-synucleinopathy. This work aimed to describe Hr-QoL progression during the natural course of MSA, explore disparities between patients and identify informative items using a four-step statistical strategy.

View Article and Find Full Text PDF

Alzheimer's disease is strongly linked to metabolic abnormalities. We aimed to distinguish amyloid-positive people who progressed to cognitive decline from those who remained cognitively intact. We performed untargeted metabolomics of blood samples from amyloid-positive individuals, before any sign of cognitive decline, to distinguish individuals who progressed to cognitive decline from those who remained cognitively intact.

View Article and Find Full Text PDF